Stifel Financial
DYN icon

Stifel Financial’s Dyne Therapeutics DYN Stock Holding History

Stifel Financial’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Buy
+16,028
New +$276K ﹤0.01% 3204
2021
Q1 		– Sell
-26,038
Closed -$547K – 3230
2020
Q4 		$547K Buy
+26,038
New +$515K ﹤0.01% 2266

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Stifel Financial's DYN Position: Q1 2026 in Review

Stifel Financial opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 16,028 shares worth $291K. The stake represents ﹤0.01% of the portfolio and ranks #3204 among its holdings. This is a return to the name: Stifel Financial previously reported a position in DYN as recently as Q4 2020.

Stifel Financial first reported a position in DYN in Q4 2020 and has held it in 2 quarters since. The position peaked at $547K in Q4 2020. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Stifel Financial held 16,028 shares of Dyne Therapeutics worth $291K as of Q1 2026.
  • Dyne Therapeutics was a new Stifel Financial position in Q1 2026.
  • Dyne Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #3204 holding.
  • Stifel Financial first reported a position in Dyne Therapeutics in Q4 2020 and has held it in 2 quarters since.
  • Stifel Financial's Dyne Therapeutics position peaked at $547K in Q4 2020.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.